Discontinuation of antithrombotic management following left atrial appendage occlusion in high bleeding risk patients

Back

ESC2025 Premium Access

Discontinuation of antithrombotic management following left atrial appendage occlusion in high bleeding risk patients

Session: Outcomes and strategies in left atrial appendage closure

Topic: Left Atrial Appendage (LAA) Closure

Speaker: Doctor S. Wong (Brighton, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Siu Fung Wong

Royal Sussex County Hospital, Brighton (United Kingdom of Great Britain & Northern Ireland)

0 follower

4 more presentations in this session

Impact of left atrial appendage closure on events after severe bleeding in anticoagulated patients with atrial fibrillation: real life data from the PERSEO registry

Speaker: Doctor M. Ruiz Ortiz (Cordoba, ES)

Left atrial appendage closure in patients with cardioembolic stroke despite oral anticoagulant therapy: a multicenter case-control study

Speaker: Doctor L. De Luca (Milan, IT)

An observational analysis of device-related thrombus in patients with atrial fibrillation across different generations of Watchman devices

Speaker: Doctor K. Pant (New York City, US)

Antithrombotic strategies and DOAC dosing following left atrial appendage occlusion: a network meta-analysis

Speaker: Doctor A. Samaras (Thessaloniki, GR)

Access the full session

Outcomes and strategies in left atrial appendage closure

Speakers: Doctor S. Wong, Doctor M. Ruiz Ortiz, Doctor L. De Luca, Doctor K. Pant, Doctor A. Samaras

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources